$1.1 Million Revenue Clinical Research Company in Texas with Strong Study Pipeline
Texas Clinical Research Company Operating Since 2006
On NextCompany since August 27, 2026 (today)
TX areaEstablished 20069 FT employees
Business overview
A clinical research company manages trials in Texas since 2006. It serves approximately 25 active pharmaceutical clients. Nine full-time employees support operations. Revenue projects to 1,100,000 dollars in 2026. Adjusted EBITDA reaches 350,000 dollars then. Real estate stays separate from the sale. The owner transitions into retirement.
Who is a good fit for this business
- Strategic buyers expanding clinical research in Texas suit this company.
- Acquirers seeking scalable trial management match the 25 active clients.
- Investors comfortable with separate real estate consider this opportunity.
Details
- Reason for selling
- The primary owner is seeking to transition into retirement over the next few years.
- Real estate
- Owned, available separately
Frequently Asked Questions
The company manages clinical trials for pharmaceutical firms. It has operated since 2006. Approximately 25 active clients support the pipeline.
Revenue projects to 1,100,000 dollars in 2026. Adjusted EBITDA reaches 350,000 dollars. Real estate remains excluded from the 3,000,000 dollar price.
The primary owner seeks retirement transition. The owner stays for a mutually agreed period. The asking price totals 3,000,000 dollars.
Nine full-time employees support operations. Six to eight contract employees assist as needed. The model scales with new studies.
The company is headquartered in a major Texas metropolitan area. It serves pharmaceutical companies. Real estate stays separate from the sale.